Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,022 | -1,296 | -2,322 | -168 | 508 |
| Depreciation Amortization | 2,450 | 2,284 | 1,538 | 904 | 802 |
| Income taxes - deferred | -15 | 25 | 462 | -285 | 236 |
| Accounts receivable | -160 | -705 | 412 | -330 | -278 |
| Accounts payable and accrued liabilities | 300 | -89 | 80 | 449 | -81 |
| Other Working Capital | 532 | -1,096 | 303 | 533 | -1,874 |
| Other Operating Activity | -770 | 1,109 | -846 | 73 | 463 |
| Operating Cash Flow | $1,316 | $234 | $-373 | $1,176 | $-222 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,457 | -2,453 | N/A | 5,450 | -499 |
| PPE Investments | -4,027 | -941 | -1,780 | -17,715 | -3,555 |
| Net Acquisitions | N/A | -9 | -14 | -9 | -470 |
| Investing Cash Flow | $-2,570 | $-3,403 | $-1,794 | $-12,274 | $-4,524 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,538 | N/A | 1,194 | 6,146 | 0 |
| Common Stock Issued | 0 | 8,303 | 96 | 3,818 | 8,506 |
| Other Financing Activity | -9,627 | -1,361 | -400 | -218 | -183 |
| Financing Cash Flow | $1,911 | $6,942 | $890 | $9,746 | $8,324 |
| Beginning Cash Position | 6,293 | 2,521 | 3,799 | 5,150 | 1,573 |
| End Cash Position | 6,950 | 6,293 | 2,521 | 3,799 | 5,150 |
| Net Cash Flow | $657 | $3,772 | $-1,278 | $-1,352 | $3,577 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,316 | 234 | -373 | 1,176 | -222 |
| Capital Expenditure | -4,073 | -1,391 | -2,030 | -17,760 | -3,586 |
| Free Cash Flow | -2,757 | -1,158 | -2,403 | -16,584 | -3,809 |